DrugInformer Search

User Voices for Pemetrexed Disodium

The following are comments from users that experienced side effects while taking Pemetrexed Disodium

Myocardial Infarction

worked good but i had severe heart attack at age 39. always felt there was something bad about this med.


Source: Celebrex Oral : User Ratings covering ...

View full report on related myocardial infarction

Did the author experience myocardial infarction while taking pemetrexed disodium?

What is this?

Myocardial Infarction

... while on the med as well, causing bloody stools. I quit taking it after the Viox (sp) recall. Both are cox-2 inhibitors which have been linked to stroke and heart attacks . Dangerous treatment....


Source: Celebrex Oral : User Ratings covering ...

View full report on related myocardial infarction

Did the author experience myocardial infarction while taking pemetrexed disodium?

What is this?

Myocardial Infarction

... while on the med as well, causing bloody stools. I quit taking it after the Viox (sp) recall. Both are cox-2 inhibitors which have been linked to stroke and heart attacks . Dangerous treatment....


Source: Celebrex Oral : User Ratings covering ...

View full report on related myocardial infarction

Did the author experience myocardial infarction while taking pemetrexed disodium?

What is this?

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.